About Creso Pharma
Creso Pharma is a company based in Perth (Australia) founded in 2015 was acquired by PharmaCielo in June 2019. Creso Pharma has completed 4 acquisitions, including Halucenex, Health House International and Mernova. Creso Pharma operates in a competitive market with competitors including Sanity Group, ZYUS Life Sciences, PharmaJet, Arecor and Suono Bio, among others.
- Headquarter Perth, Australia
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
PharmaCielo
& 1 more
-
Employee Count
Not available
-
Investments & Acquisitions
Halucenex
& 3 more
-
Acquired by
PharmaCielo
(Jun 06, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Creso Pharma
Investors in Creso Pharma
Creso Pharma has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include PharmaCielo and EverBlu Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Medicinal cannabis oil and products are produced in Colombia.
|
Locked | Locked | Locked |
Investor details for Creso Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Creso Pharma
Creso Pharma has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Halucenex, Health House International and Mernova.
Investment portfolio details for Creso Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Psychedelic drugs for mental illness treatment are developed by Halucenex.
|
Locked | Locked | 2019 | Locked | |
|
Cannabis medical services are provided to patients in Australia.
|
Locked | Locked | 2014 | Locked | |
|
Cannabis is produced and supplied by Mernova in Canada.
|
Locked | Locked | 2014 | Locked |
Complete acquisition details for Creso Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Creso Pharma
Detailed financials for Creso Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Creso Pharma Comparisons
Peer comparison for Creso Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Creso Pharma
Creso Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sanity Group, ZYUS Life Sciences, PharmaJet, Arecor and Suono Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of cannabinoid-based pharmaceuticals and well-being products
|
|
| Locked | Locked | Locked |
Cannabis-derived therapeutics for multiple indications are developed.
|
|
| Locked | Locked | Locked |
Provider of needle-free injection technology
|
|
| Locked | Locked | Locked |
Developer of proteins, vaccines based on proprietary stabilization technologies for drug delivery
|
|
| Locked | Locked | Locked |
Developer of technology to enable ultra-rapid delivery of therapeutics to the gastrointestinal tract
|
|
| Locked | Locked | Locked |
Drug delivery solutions via single-walled carbon nanotubes are offered.
|
Detailed competitors of Creso Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Creso Pharma
Complete news archive for Creso Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Creso Pharma
Creso Pharma was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Creso Pharma is headquartered in Perth, Australia. It is registered at Perth, Western Australia, Australia.
Marc Lustig is the current CEO of Creso Pharma.
Creso Pharma was founded in 2015 and is headquartered in Perth, Australia. Operations focus on the biotechnology sector, where cannabinoid therapeutics are developed using nanotechnology for both human and veterinary uses. Lead products include a cannabidiol hemp oil-based complementary feed for companion animals and a nutraceutical targeted at human health. The company addresses multiple health purposes through these formulations.
Creso Pharma's top competitors include PharmaJet, Splice Bio and ZYUS Life Sciences.
Creso Pharma has made 4 acquisitions, including Halucenex, Health House International, and Mernova.
Creso Pharma has 2 investors. Key investors include PharmaCielo, and EverBlu Capital.